Close

Amgen (AMGN): Little Impact Expected From Parsabiv Rejection - Baird

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. ENPH
3. TXN
4. BA
5. SPOT
6. META
7. IBM
8. V
9. KMB
10. MSFT


Go back to Amgen (AMGN): Little Impact Expected From Parsabiv Rejection - Baird
Amgen Inc (NASDAQ: AMGN) Delayed: 273.01 -0.53 (0.19%)
Previous Close $273.54    52 Week High $176.85 
Open $270.63    52 Week Low $133.64 
Day High $274.86    P/E 41.12 
Day Low $269.65    EPS $6.64 
Volume 2,467,116